Results 121 to 130 of about 30,778 (256)

RADIATION-HYGIENIC JUSTIFICATION OF OUTPATIENT RADIONUCLIDE THERAPY

Радиационная гигиена, 2015
The possibility of the use of the different therapeutic radiopharmaceuticals labeled with one of the 19 β-γ-emitting radionuclides or 6 α-β-γ-emitting radionuclides in the outpatient regime was identified in the estimateinvestigations.
B. Ja. Narkevich, S. V. Shiryaev, A. N. Klyopov, N. N. Lipanova, Yu. V. Lysak   +4 more
doaj  

Patient organ and effective dose estimation in radionuclide therapy with ²²³Ra -dichloride

, 2020
Л. А. Чипига, A. E. Petrova, А. В. Водоватов, A. A. Stanzhevsky, A. A. Lumpov, D. D. Lavreshov, L. E. Naurzbaeva, Stanislaus M. Kushnarenko, A. A. Mosunov   +8 more
openalex   +2 more sources

Targeted Radionuclide Therapy

, 2022
The aim of this work is to improve the current computational dosimetry approaches for in vitro and in vivo TRT treatment in order to correlate microdosimetry with biological effects. The creation of such computational frameworks and the investigation of the radiobiology of dose-response in TRT in cells and in small animals can ultimately lead to a ...
openaire   +1 more source

Foam Sclerotherapy Alleviates Dermatological Symptoms of Lipodermatosclerosis of the Lower Extremities

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
Introduction Chronic venous disease (CVD) is a prevalent vascular condition that manifests through varicose veins and a variety of clinical symptoms. Lipodermatosclerosis (LDS), a severe complication of CVD, is characterized by pain, skin fibrosis, and significant impairment of the quality of life.
Yu-Ting Tsai, Shang-Hung Lin, Suraiya Saleem   +2 more
wiley   +1 more source

Targeted radionuclide therapy frontiers in theranostics

, 2017
Francesca Gallivanone
openalex   +2 more sources

The effect of nucleus size on the cell dose in targeted radionuclide therapy – A monte carlo study

, 2020
Ebrahim Kouhkan, Nahid Chegeni, Amjad Hussain   +2 more
openalex   +1 more source

Early Low‐Dose Rituximab for Mild‐to‐Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety

International Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Background Thyroid eye disease (TED) is an autoimmune inflammatory condition linked to thyroid dysfunction, which can result in disfigurement and potential vision loss. Recently, immunomodulatory therapies such as rituximab have demonstrated potential benefit in managing TED.
Ming Lu, Luqiang Wang, Xuelian Zhang, Suraiya Saleem   +3 more
wiley   +1 more source

Implications of Innovative Nuclear Technologies on Ghana’s Nuclear Future

Science and Technology of Nuclear Installations, Volume 2026, Issue 1, 2026.
Innovations in nuclear technology have the potential to play a transformative role in Ghana’s pursuit of a secure, reliable and low‐carbon energy future. This review examines recent global advances in nuclear reactor technologies, fuel cycle systems, waste management approaches, regulatory practices and digital applications and assesses their relevance
R. G. Abrefah, B. K. A. Baiden, F. Ameyaw, S. A. Zakaria, Doddy Kastanya   +4 more
wiley   +1 more source

Rational Radionuclide Therapy for Recurrent Meningioma. [PDF]

J Nucl Med
Chen WC, Raleigh DR.
europepmc   +1 more source

The 20th International Conference on Radionuclide Therapy (ICRT 2025). [PDF]

World J Nucl Med
Frangos S.
europepmc   +1 more source